1. Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease
   Julio M. Martinez-Moreno et al, 2020, International Journal of Molecular Sciences CrossRef
2. A BRD’s (BiRD’s) eye view of BET and BRPF bromodomains in neurological diseases
   Harish Iyer et al, 2021, Reviews in the Neurosciences CrossRef
3. The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms
   Teresa Salvatore et al, 2021, Frontiers in Medicine CrossRef
4. Bromodomain‐containing protein 4 and its role in cardiovascular diseases
   Liang Li et al, 2021, Journal of Cellular Physiology CrossRef
5. BRD2 protects the rat H9C2 cardiomyocytes from hypoxia‑reoxygenation injury by targeting Nrf2/HO‑1 signaling pathway
   Yingcun Liu et al, 2023, Experimental and Therapeutic Medicine CrossRef
6. Research Progress on Epigenetics of Diabetic Cardiomyopathy in Type 2 Diabetes
   Jianxin Deng et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
7. Mesenchymal Stem Cell Therapy in Diabetic Cardiomyopathy
   Jaqueline S. da Silva et al, 2022, Cells CrossRef
8. A Comprehensive Review of BET Protein Biochemistry, Physiology, and Pathological Roles
   Hafiz Akbar Ali et al, 2022, Frontiers in Pharmacology CrossRef
9. A New Family of Fused Azolo[1,5-a]pteridines and Azolo[5,1-b]purines
   Denis A. Gazizov et al, 2020, ACS Omega CrossRef